0000051143 false Capital stock, par value $.20 per share IBM CHX 0000051143 2022-04-26 2022-04-26 0000051143 us-gaap:CommonStockMember exch:XCHI 2022-04-26 2022-04-26 0000051143 us-gaap:CommonStockMember exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes2.625PercentDue2022Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes1.25PercentDue2023Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes0.375PercentDue2023Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes1.125PercentDue2024Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes2.875PercentDue2025Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes0.950PercentDue2025Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes0.875PercentDue2025Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes0.300PercentDue2026Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes1.250PercentDue2027Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes0.300PercentDue2028Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes1.750PercentDue2028Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes1.500PercentDue2029Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes0.875PercentDue2030Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes1.250PercentDue2034Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Notes1.750PercentDue2031Member exch:XNYS 2022-04-26 2022-04-26 0000051143 exch:XNYS ibm:Notes0.650PercentDue2032Member 2022-04-26 2022-04-26 0000051143 exch:XNYS ibm:Notes1.200PercentDie2040Member 2022-04-26 2022-04-26 0000051143 ibm:Debentures7.00PercentDue2025Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Debentures6.22PercentDue2027Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Debentures6.50PercentDue2028Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Debentures7.00PercentDue2045Member exch:XNYS 2022-04-26 2022-04-26 0000051143 ibm:Debentures7.125PercentDue2096Member exch:XNYS 2022-04-26 2022-04-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

Title of each class
Trading symbol

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549  

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)

OF THE SECURITIES EXCHANGE ACT OF 1934 

 

Date of Report : April 26, 2022

(Date of earliest event reported)

 

 

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

New York   1-2360   13-0871985
(State of Incorporation)   (Commission File Number)   (IRS employer Identification No.)

 

One New Orchard Road

    
Armonk, New York   10504
(Address of principal executive offices)   (Zip Code)

 

914-499-1900

(Registrant’s telephone number)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange
on which registered
Capital stock, par value $.20 per share   IBM   New York Stock Exchange
        NYSE Chicago
2.625% Notes due 2022   IBM 22A   New York Stock Exchange
1.250% Notes due 2023   IBM 23A   New York Stock Exchange
0.375% Notes due 2023   IBM 23B   New York Stock Exchange
1.125% Notes due 2024   IBM 24A   New York Stock Exchange
2.875% Notes due 2025   IBM 25A   New York Stock Exchange
0.950% Notes due 2025   IBM 25B   New York Stock Exchange
0.875% Notes due 2025   IBM 25C   New York Stock Exchange
0.300% Notes due 2026   IBM 26B   New York Stock Exchange
1.250% Notes due 2027   IBM 27B   New York Stock Exchange
0.300% Notes due 2028   IBM 28B   New York Stock Exchange
1.750% Notes due 2028   IBM 28A   New York Stock Exchange
1.500% Notes due 2029   IBM 29   New York Stock Exchange
0.875% Notes due 2030   IBM 30   New York Stock Exchange
1.750% Notes due 2031   IBM 31   New York Stock Exchange
0.650% Notes due 2032   IBM 32A   New York Stock Exchange
1.250% Notes due 2034   IBM 34   New York Stock Exchange
1.200% Notes due 2040   IBM 40   New York Stock Exchange
7.00% Debentures due 2025   IBM 25   New York Stock Exchange
6.22% Debentures due 2027   IBM 27   New York Stock Exchange
6.50% Debentures due 2028   IBM 28   New York Stock Exchange
7.00% Debentures due 2045   IBM 45   New York Stock Exchange
7.125% Debentures due 2096   IBM 96   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

(a)International Business Machines Corporation (IBM) held its Annual Meeting of Stockholders on April 26, 2022. Below are the final voting results. For more information on the following proposals, see IBM’s proxy statement dated March 7, 2022, the relevant portions of which are incorporated herein by reference.

 

(b)Election of Directors for a Term of One Year:

 

DIRECTOR  FOR   AGAINST   ABSTAIN   BROKER
NON-VOTES		 
T. Buberl   512,637,798    19,408,925    4,938,318    156,937,839 
D.N. Farr   519,777,197    12,298,952    4,908,892    156,937,839 
A. Gorsky   485,553,123    46,605,407    4,826,511    156,937,839 
M. Howard   523,505,493    9,039,546    4,440,002    156,937,839 
A. Krishna   496,032,233    35,527,242    5,425,566    156,937,839 
A.N. Liveris   350,899,075    180,880,781    5,205,185    156,937,839 
F.W. McNabb III   522,234,880    9,685,670    5,064,491    156,937,839 
M.E. Pollack   522,938,417    9,585,516    4,461,108    156,937,839 
J.R. Swedish   521,023,719    10,955,761    5,005,561    156,937,839 
P.R. Voser   519,656,314    12,350,599    4,978,128    156,937,839 
F.H. Waddell   513,406,371    18,585,003    4,993,667    156,937,839 
A.W. Zollar   517,825,968    14,323,443    4,835,630    156,937,839 

 

Ratification of Appointment of Independent Registered Public Accounting Firm:

 

For   656,967,636    95.2%
Against   32,830,338    4.8%
Abstain   4,124,906      

 

Management Proposal on Advisory Vote on Executive Compensation (Say on Pay):

 

For   473,874,456    89.6%
Against   55,096,187    10.4%
Abstain   8,014,398      
Broker Non-Votes   156,937,839      

 

Stockholder Proposal on Stockholder Special Meeting Right:

 

For   187,771,875    35.5%
Against   340,686,181    64.5%
Abstain   8,526,985      
Broker Non-Votes   156,937,839      

 

Stockholder Proposal to Have an Independent Board Chairman:

 

For   211,119,750    39.8%
Against   318,877,167    60.2%
Abstain   6,988,124      
Broker Non-Votes   156,937,839      

 

Stockholder Proposal Requesting a Public Report on the Use of Concealment Clauses:

 

For   339,827,195    64.7%
Against   185,380,818    35.3%
Abstain   11,777,028      
Broker Non-Votes   156,937,839      

 

2

 

 

IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

Date:  April 29, 2022  
   
     
  By: /s/ Frank Sedlarcik
    Frank Sedlarcik
    Vice President, Assistant General Counsel and Secretary

 

4